Thursday, August 28, 2014

Health Benefits of Aspirin and Statins



Edited by Jonathan D. Kantrowitz

Published by Tsadek Press

Copyright, Jonathan Kantrowitz 2014


8.5 x 11, 154 pages
$12.95

Tsadek Press books $19.95
Tsadek Press books $24.95

Call 1-800-232--2224 to order a pdf of this title

Description:


Aspirin was considered a wonder drug when first discovered, but the latest research shows that aspirin is truly a wonder drug today. Prevention of heart attacks and strokes is just the beginning. Aspirin also works wonders in fighting many kinds of cancer. Aspirin slows or prevents cognitive declines as well. You need to read this book to learn about all these wonders, and many other benefits too numerous to mention, of regular aspirin consumption. 


Statins are prescribed to lower cholesterol in the US, but are available over the counter in Great Britain. Not only do statins prevent heart attacks, but, much like aspirin, they offer so many other benefits that they extend the life of their users significantly. 


Read all about it in this indispensable book!






Table of Contents



ASPIRIN

Heart Attack and Stroke Benefits       

Cancer Benefits                                                                      
            Breast and Ovarian Cancer                 
            Colorectal Cancer                   
            Pancreatic Cancer                   
            Prostate Cancer                      
            Skin Cancer                            
            Other Cancers                        
            All Cancers                             

Cognitive Decline/Dementia Benefits

Liver Disease/Damage Benefits          

Osteoporosis (Bone) Benefits              

Miscellaneous Benefits                      

Risks                                                  

STATINS



Benefit of Statins

Mortality                                                        
Cardiovascular                                                
Cancer                                                            
Parkinson's Disease                                       
Pneumonia                                                     
Gall Bladder Disease                                      




Miscellaneous Benefits                                  

Possible Negatives

Statins May Cause Muscle Problems             
Statins May Cause Diabetes                           
Statins May Cause Fatigue and Depression   
Statins May/May Not Increase Risk of Cataracts
More Negative Side Effects                            
Statins May Not Have Side Effects After All 
Coenzyme Q10 May Reduce Statin Risks     

Last Minute Additions  - Latest Research Reports

Aspirin
Statins
__________________________________________________________________________

Sample articles:

Bedtime aspirin may reduce risk of morning heart attack

Taking aspirin at bedtime instead of in the morning might reduce acute heart events, according a new study presented at the American Heart Association's Scientific Sessions 2013.

Low-dose daily aspirin is recommended for people at high risk of heart disease and for reducing the risk of recurrent heart events. Aspirin thins the blood and makes it less likely to clot. The tendency for platelet activity to be higher peaks in the morning.

The Aspirin in Reduction of Tension II trial is the first study to explore the timing of aspirin intake among cardiovascular disease patients. In the randomized, open-label study, 290 patients took either 100 mg of aspirin upon waking or at bedtime during two 3-month periods. At the end of each period, blood pressure and platelet activity was measured.

Blood pressure was not reduced; however, bedtime aspirin platelet activity was reduced by 22 units (aspirin reaction units).

"Because higher platelet activity contributes to a higher risk of acute heart events, this simple intervention – switching aspirin intake from morning to bedtime – could be beneficial for the millions of patients with heart disease who take aspirin on a daily basis," said Tobias Bonten, M.D., Ph.D student at the Leiden University Medical Center in the Netherlands.


Why Don't More Women Take a Daily Aspirin to Prevent Heart Disease?

Heart disease is the leading cause of death among women, and evidence-based national guidelines promote the use of daily aspirin for women at increased risk for cardiovascular disease. However, less than half of the women who could benefit from aspirin are taking it, according to an article in Journal of Women’s Health, a peer-reviewed publication from Mary Ann Liebert, Inc.

“Based on this survey, it is evident that the majority of women for whom aspirin is recommended for prevention of cardiovascular disease are not following national guidelines,” says Editor-in-Chief Susan G. Kornstein, MD.

Among more than 200,000 women participating in a web-based survey to assess their risk for cardiovascular disease, only 41%-48% of women for whom aspirin is recommended reported that they took an aspirin daily, according to the study authors, Cathleen Rivera, MD and Texas-based colleagues from Scott and White Healthcare, Navigant Healthcare Consultants, and Texas A&M Health Science Center.

The women were more likely to use aspirin if they had a family history of cardiovascular disease or had high cholesterol, as reported in the article “Underuse of Aspirin for Primary and Secondary Prevention of Cardiovascular Disease Events in Women.” The authors conclude that improved educational programs are needed to increase awareness of the benefits of aspirin use to prevent heart disease among women.


Aspirin: High or Low Dose? No significant difference in preventing recurring cardiovascular events

Researchers report no significant difference in high versus low dose aspirin in preventing recurring cardiovascular events.

Each year, more than one million Americans suffer a heart attack and nearly all patients are prescribed a daily aspirin and an antiplatelet medication during recovery. However, the optimal aspirin dose has been unclear. Now, new research from Brigham and Women's Hospital (BWH) reports that there is no significant difference between high versus low dose aspirin in the prevention of recurring cardiovascular events in patients who suffer from acute coronary syndromes (ACS), which are characterized by symptoms related to obstruction in coronary arteries, which supply blood to the heart. These findings were presented at the American College of Cardiology Scientific Sessions on March 24, 2012.

"We observed no difference between patients taking a high dose versus a low of aspirin as it relates to cardiovascular death, heart attack, stroke or stent thrombosis," said Payal Kohli, MD,cardiology fellow at BWH and researcher in the TIMI Study Group, who is the lead author on this study. "Interestingly, we did find a dramatic difference in practice patterns of physicians in North America compared to those in the rest of the world," Kohli said. "North American physicians prescribed a high dose of aspirin for two-thirds of all their patients, while the exact reverse was true of the rest of the world. International physicians prescribed a low dose of aspirin to more than two-thirds of their patients." Dr. Stephen D. Wiviott, a cardiologist at BWH and researcher in the TIMI Study Group, is the senior author on the study.

Researchers analyzed data from more than 11000 patients from around the world that were enrolled in the TRITON-TIMI 38 trial, which randomized ACS patients to receive either clopidigrel or prasugrel, two different antiplatelet medications. Some patients were prescribed high doses of aspirin following a heart attack, while others, low doses. The aspirin dose was prescribed at the clinician investigator's discretion and the analysis included 7,106 patients who received low dose aspirin, defined as 150 mg or less, and 4,610 patients who received high dose aspirin, defined as 150 mg or more. Researchers reported that there was no significant difference observed in the prevention of the combination of heart attack, stroke, cardiovascular death or the prevention of stent thrombosis between the groups that received high or low dose aspirin.


No comments:

Post a Comment